Adverum Biotechnologies
ADVMAdverum Biotechnologies, publicly traded (NASDAQ:ADVM) is a clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, designed as a one- …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Adverum Biotechnologies
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 7/30/2024 | Buy | Leonard, Braden Michael | Ten Percent Owner | $7.2 | $613,470 |
| 7/18/2024 | Buy | Leonard, Braden Michael | Ten Percent Owner | $9.1 | $735,736 |
| 7/17/2024 | Buy | Leonard, Braden Michael | Ten Percent Owner | $7.7 | $1,049,926 |
| 2/7/2024 | Buy | Lupher,, Jr. Mark L. | Director | $1.4 | $175,500 |
| 2/7/2024 | Buy | Scopa, James Paul | Director | $1.4 | $135,000 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)